In addition, innovative immunotherapies focused on enhancing T cell activity through modification of T cell N-glycosylation could avoid the differentiation of naive CD4+ T cells into regulatory or exhaustion phenotypes that favor tumor immune evasion and it is usually observed in precancerous conditions and in tumor microenvironment (Figure 1) [124,125,126,127,128]. Here, CD4 is linked to neoplasm.